CRS and HIPEC for pancreatic ductal adenocarcinoma with peritoneal metastases: a case report

Background: Pancreatic ductal adenocarcinoma (PDAC) is aggressive, with more than 80% present with metastatic disease, and an overall survival of less than a year with systemic chemotherapy treatment. Cytoreductive surgery (CRS) and intraperitoneal chemotherapy are two treatment modalities being exp...

Full description

Saved in:
Bibliographic Details
Main Authors: Amin-Tai, Hizami, Adznan, Muhammad Ash-Shafhawi, Canda, Aras Emre, Yılmaz, Hüseyin Cahit, Kılıç, Murat, Terzi, Mustafa Cem
Format: Article
Language:English
Published: Surgical Society of North Greece 2023
Online Access:http://psasir.upm.edu.my/id/eprint/107180/1/CRS%20and%20HIPEC%20for%20pancreatic%20ductal%20adenocarcinoma%20with%20peritoneal%20metastases.pdf
http://psasir.upm.edu.my/id/eprint/107180/
https://www.surgchronicles.gr/components/com_journals/journals/2023/4/22.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!